Article Details

Setback: Mylan proposal for Hydroxychloroquine Sulfate Tablet rejected by CDSCO panel

Retrieved on: 2021-08-06 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Setback: Mylan proposal for Hydroxychloroquine Sulfate Tablet rejected by CDSCO panel. View article details on hiswai:

Excerpt

This came after Mylan Laboratories presented a proposal for the manufacturing and marketing of Hydroxychloroquine Sulfate Tablet 100 mg in India, ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up